Skip to main content
. 2019 Jun;8(3):736–751. doi: 10.21037/tcr.2019.04.10

Table 11. Stage differences in patients with mutations.

Mutated genes IV Non-IV P value
Cases Mutation rate (%) Cases Mutation rate (%)
Total 65 57.52 6 5.31 0.0105
EGFR 45 47.37 4 22.22 0.0864
ALK 7 7.37 0 0 0.5949
ROS1 4 4.21 0 0 1.0000
MET 2 2.11 2 11.11 0.1186
ERBB2 (Her2) 4 4.21 0 0 1.0000
BRAF 2 2.11 0 0 1.0000
KRAS 7 7.37 1 5.56 1.0000